Orphazyme

-$0.01 (-0.18%) Today
$0.00 (0.00%) As of 8:58 AM UTC after-hours

Why Robinhood?

You can buy or sell Orphazyme and other stocks, options, and ETFs commission-free!

About ORPH

Orphazyme A/S American Depositary Shares, also called Orphazyme, is a biopharmaceutical company, which engages in the development of treatment for patients living with life-threatening and debilitating rare diseases. It provides Arimoclomol program and molecular entities program.

CEO
Christophe Bourdon
Employees
141
Headquarters
Copenhagen, Capital Region
Founded
2009

ORPH Key Statistics

Market Cap
206.90M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
25.39K
High Today
$5.75
Low Today
$5.41
Open Price
$5.75
Volume
7.49K
52 Week High
$14.78
52 Week Low
$5.41

You May Also Like

NBY
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure